(Q30419020)

English

Fenofibrate-associated changes in renal function and relationship to clinical outcomes among individuals with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) experience

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Fenofibrate-associated changes in renal function and relationship to clinical outcomes among individuals with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) experience (English)

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

type 2 diabetes

1 reference

based on heuristic

Santica M Marcovina

9

object named as

S Marcovina

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

JoAnn Sperl-Hillen

12

object named as

J-A Sperl-Hillen

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

author name string

D E Bonds

1

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

T E Craven

2

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

J Buse

3

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

J R Crouse

4

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

R Cuddihy

5

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

M Elam

6

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

H N Ginsberg

7

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

K Kirchner

8

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

J C Mychaleckyj

10

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

P J O'Connor

11

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

language of work or name

1 reference

based on heuristic

publication date

27 March 2012

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

55

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

6

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

1641-1650

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

https://scigraph.springernature.com/pub.10.1007/s00125-012-2524-2

0 references

Use of fibrates in the United States and Canada

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374398

20 June 2018

Effects of combination lipid therapy in type 2 diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374398

20 June 2018

Effects of long-term fenofibrate treatment on markers of renal function in type 2 diabetes: the FIELD Helsinki substudy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374398

20 June 2018

A new equation to estimate glomerular filtration rate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374398

20 June 2018

Effects of intensive glucose lowering in type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374398

20 June 2018

Evolution of the lipid trial protocol of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374398

20 June 2018

Increasing or stabilizing renal epoxyeicosatrienoic acid production attenuates abnormal renal function and hypertension in obese rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374398

20 June 2018

Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374398

20 June 2018

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374398

20 June 2018

Response to micronized fenofibrate treatment is associated with the peroxisome-proliferator-activated receptors alpha G/C intron7 polymorphism in subjects with type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374398

20 June 2018

Peroxisome proliferator-activated receptors and cardiovascular remodeling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374398

20 June 2018

Peroxisome proliferator-activated receptor alpha target genes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374398

20 June 2018

Effect of ciprofibrate on lipoproteins, fibrinogen, renal function, and hepatic enzymes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374398

20 June 2018

Design and intermediate results of the Lower Extremity Arterial Disease Event Reduction (LEADER)* trial of bezafibrate in men with lower extremity arterial disease [ISRCTN4119421

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374398

20 June 2018

Comparative effects of cerivastatin and fenofibrate on the atherogenic lipoprotein phenotype in proteinuric renal disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374398

20 June 2018

Fibrate-induced increase in blood urea and creatinine: is gemfibrozil the only innocuous agent?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374398

20 June 2018

Long-term efficacy and safety of fenofibrate and a statin in the treatment of combined hyperlipidemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374398

20 June 2018

Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: results from the Diabetes Atherosclerosis Intervention Study (DAIS).

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2524-2

21 January 2018

Fibrate-induced increase in blood urea and creatinine

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2524-2

21 January 2018

Effect of fenofibrate on kidney function: a 6-week randomized crossover trial in healthy people

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2524-2

21 January 2018

Effect of rosiglitazone on homocysteine and creatinine levels in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2524-2

21 January 2018

The low dose combination of fenofibrate and rosiglitazone halts the progression of diabetes-induced experimental nephropathy

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2524-2

21 January 2018

A note on a general definition of the coefficient of determination

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2524-2

21 January 2018

Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2524-2

21 January 2018

Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial: Design and Methods

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2524-2

21 January 2018

Fenofibrate increases blood creatinine, but does not change the glomerular filtration rate in patients with mild renal insufficiency

1 reference

https://pubmed.ncbi.nlm.nih.gov/22450889

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fenofibrate increases creatininemia by increasing metabolic production of creatinine

1 reference

https://pubmed.ncbi.nlm.nih.gov/22450889

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00125-012-2524-2

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30419020&oldid=1871658828"